The Valley Desk

NCT00000751 · Interventional trial

A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)

Overall registry status Completed

Phase 3

Conditions HIV Infections, Pregnancy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov